Effects of bilateral deep brain stimulation of the subthalamic nucleus on olfactory function in Parkinson's disease patients

Stereotactic and Functional Neurosurgery

Volumn 86, Issue 4, 2008, Pages 237-244

  Guo, Xiaodong ^a   Gao, Guodong ^a   Wang, Xuelian ^a   Li, Lihong ^a   Li, Weixin ^a   Liang, Qinchuan ^a   Zhang, Hua ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Deep brain stimulation; Detection threshold; Identification threshold; Olfaction; Parkinson's disease; Subthalamic nucleus

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; ELECTRODE; FEMALE; FOLLOW UP; HUMAN; MALE; MOTOR PERFORMANCE; NEUROSURGERY; PARKINSON DISEASE; POSTOPERATIVE PERIOD; SMELLING; SUBTHALAMIC NUCLEUS; SYMPTOMATOLOGY; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; DEEP BRAIN STIMULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; ODORS; PARKINSON DISEASE; SMELL; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME;

EID: 46749104518     PISSN: 10116125     EISSN: None     Source Type: Journal    
DOI: 10.1159/000131662     Document Type: Article

References (49)

1. Müller A, Reichmann H, Livermore A, Hummel T: Olfactory function in idiopathic Parkinson's disease (IPD): results from cross-sectional studies in IPD patients and longterm follow-up of de-novo IPD patients. J Neural Transm 2002;109:805-811.
2. Henderson JM, Lu Y, Wang S, Cartwright H, Halliday GM: Olfactory deficits and sleep disturbances in Parkinson's disease: a case-control survey. J Neurol Neurosurg Psychiatry 2003;74:956-958.
3. Tissingh G, Berendse HW, Bergmans P, DeWaard R, Drukarch B, Stoof JC, Wolters EC: Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis. Mov Disord 2001;16:41-46.
4. Huisman E, Uylings HB, Hoogland PV: A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease. Mov Disord 2004;19:687-692.
5. Ponsen MM, Stoffers D, Booij J, van Eck-Smit BL, Wolters ECh, Berendse HW: Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol 2004;56:173-181.
6. Hawkes C: Olfaction in neurodegenerative disorder. Mov Disord 2003;18:364-372.
7. Kim JY, Lee WY, Chung EJ, Dhong HJ: Analysis of olfactory function and the depth of olfactory sulcus in patients with Parkinson's disease. Mov Disord 2007;22:1563-1566.
8. Braak H, Bohl JR, Müller CM, Rüb U, de Vos RA, Del Tredici K: Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered. Mov Disord 2006;21:2042-2051.
9. Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E: Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211.
10. Lee PH, Yeo SH, Kim HJ, Youm HY: Correlation between cardiac 123 I-MIBG and odor identification in patients with Parkinson's disease and multiple system atrophy. Mov Disord 2006;21:1975-1977.
11. Doty RL, Singh A, Tetrud J, Langston JW: Lack of major olfactory dysfunction in MPTP-induced parkinsonism. Ann Neurol 1992;32:97-100.
12. Miwa T, Watanabe A, Mitsumoto Y, Furukawa M, Fukushima N, Moriizumi T: Olfactory impairment and Parkinson's disease-like symptoms observed in the common marmoset following administration of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine. Acta Otolaryngol Suppl 2004;553:80-84.
13. Temel Y, Kessels A, Tan S, Topdag A, Boon P, Visser-Vandewalle V: Behavioural changes after bilateral subthalamic stimulation in advanced Parkinson disease: a systematic review. Parkinsonism Relat Disord 2006;12:265-272.
14. Visser-Vandewalle V, van der Linden C, Temel Y, Celik H, Ackermans L, Spincemaille G, Caemaert J: Long-term effects of bilateral subthalamic nucleus stimulation in advanced Parkinson disease: a four-year followup study. Parkinsonism Relat Disord 2005;11:157-165.
15. Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C, Koudsie A, Limousin PD, Benazzouz A, LeBas JF, Benabid AL, Pollak P: Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003;349:1925-1934.
16. Liang GS, Chou KL, Baltuch GH, Jaggi JL, Loveland-Jones C, Leng L, Maccarone H, Hurtig HI, Colcher A, Stern MB, Kleiner-Fisman G, Simuni T, Siderowf AD: Long-term outcomes of bilateral subthalamic nucleus stimulation in patients with advanced Parkinson's disease. Stereotact Funct Neurosurg 2006;84:221-227.
17. Lyons KE, Davis JT, Pahwa R: Subthalamic nucleus stimulation in Parkinson's disease patients intolerant to levodopa. Stereotact Funct Neurosurg 2007;85:169-174.
18. Pahwa R, Wilkinson SB, Overman J, Lyons KE: Preoperative clinical predictors of response to bilateral subthalamic stimulation in patients with Parkinson's disease. Stereotact Funct Neurosurg 2005;83:80-83.
19. Herz RS, Eliassen J, Beland S, Souza T: Neuroimaging evidence for the emotional potency of odor-evoked memory. Neuropsychologia 2004;42:371-378.
20. Rolls ET, O'Doherty J, Kringelbach ML, Francis S, Bowtell R, McGIone F: Representations of pleasant and painful touch in the human orbitofrontal and cingulate cortices. Cereb Cortex 2003;13:308-317.
21. Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI: Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1992;55:138-142.
22. Tsuboi Y, Wszolek ZK, Graff-Radford NR, Cookson N, Dickson DW: Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein ε4. Neuropathol Appl Neurobiol 2003;29:503-510.
23. Roth J, Radil T, Růzicka E, Jech R, Tichý J: Apomorphine does not influence olfactory thresholds in Parkinson's disease. Funct Neurol 1998;13:99-103.
24. Davila NG, Blakemore LJ, Trombley PQ: Dopamine modulates synaptic transmission between rat olfactory bulb neurons in culture. J Neurophysiol 2003;90:395-404.
25. Winner B, Geyer M, Couillard-Despres S, Aigner R, Bogdahn U, Aigner L, Kuhn G, Winkler J: Striatal deafferentation increases dopaminergic neurogenesis in the adult olfactory bulb. Exp Neurol 2006;197:113-121.
26. Ross GW, Abbott RD, Petrovitch H, Tanner CM, Davis DG, Nelson J, Markesbery WR, Hardman J, Masaki K, Launer L, White LR: Association of olfactory dysfunction with incidental Lewy bodies. Mov Disord 2006;21:2062-2067.
27. Hummel T, Jahnke U, Sommer U, Reichmann H, Müller A: Olfactory function in patients with idiopathic Parkinson's disease: effects of deep brain stimulation in the subthalamic nucleus. J Neural Transm 2005;112:669-676.
28. Zelano C, Sobel N: Humans as an animal model for systems-level organization of olfaction. Neuron 2005;48:431-454.
29. Martzke JS, Kopala LC, Good KP: Olfactory dysfunction in neuropsychiatric disorders: review and methodological considerations. Biol Psychiatry 1997;42:721-732.
30. Kareken DA, Mosnik DM, Doty RL, Dzemidzic M, Hutchins GD: Functional anatomy of human odor sensation, discrimination, and identification in health and aging. Neuropsychology 2003;17:482-495.
31. Lacerda AL, Hardan AY, Yorbik O, Keshavan MS: Measurement of the orbitofrontal cortex: a validation study of a new method. Neuroimage 2003;19:665-673.
32. Hashimoto T, Elder CM, Okun MS, Patrick SK, Vitek JL: Stimulation of the subthalamic nucleus changes the firing pattern of pallidal neurons. J Neurosci 2003;23:1916-1923.
33. Lyons KE, Pahwa R: Long-term benefits in quality of life provided by bilateral subthalamic stimulation in patients with Parkinson disease. J Neurosurg 2005;103:252-255.
34. Funkiewiez A, Ardouin C, Krack P, Fraix V, Van Blercom N, Xie J, Moro E, Benabid AL, Pollak P: Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease. Mov Disord 2003;18:524-530.
35. Witt K, Pulkowski U, Herzog J, Lorenz D, Hamel W, Deuschl G, Krack P: Deep brain stimulation of the subthalamic nucleus improves cognitive flexibility but impairs response inhibition in Parkinson disease. Arch Neurol 2004;61:697-700.
36. Pillon B, Ardouin C, Damier P, Krack P, Houeto JL, Klinger H, Bonnet AM, Pollak P, Benabid AL, Agid Y: Neuropsychological changes between 'off' and 'on' STN or GPi stimulation in Parkinson's disease. Neurology 2000;55:411-418.
37. Tröster AI, Fields JA, Wilkinson S, Pahwa R, Koller WC, Lyons KE: Effect of motor improvement on quality of life following subthalamic stimulation is mediated by changes in depressive symptomatology. Stereotact Funct Neurosurg 2003;80:43-47.
38. Perozzo P, Rizzone M, Bergamasco B, Castelli L, Lanotte M, Tavella A, Torre E, Lopiano L: Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: comparison of pre- and postoperative neuropsychological evaluation. J Neurol Sci 2001;192:9-15.
39. Hilker R, Voges J, Weisenbach S, Kalbe E, Burghaus L, Ghaemi M, Lehrke R, Koulousakis A, Herholz K, Sturm V, Heiss WD: Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson's disease. J Cereb Blood Flow Metab 2004;24:7-16.
40. Wang J, Eslinger PJ, Smith MB, Yang QX: Functional magnetic resonance imaging study of human olfaction and normal aging. J Gerontol A Biol Sci Med Sci 2005;60:510-514.
41. Gottfried JA, Zald DH: On the scent of human olfactory orbitofrontal cortex: meta-analysis and comparison to non-human primates. Brain Res Rev 2005;50:287-304.
42. Gottfried JA, Winston JS, Dolan RJ: Dissociable codes of odor quality and odorant structure in human piriform cortex. Neuron 2006;49:467-479.
43. 99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease. Neurology 2005;64:1716-1720.
44. Haehner A, Hummel T, Hummel C, Sommer U, Junghanns S, Reichmann H: Olfactory loss may be a first sign of idiopathic Parkinson's disease. Mov Disord 2007;22:839-842.
45. Sommer U, Hummel T, Cormann K, Mueller A, Frasnelli J, Kropp J, Reichmann H: Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT. Mov Disord 2004;19:1196-1202.
46. Meissner W, Harnack D, Reese R, Paul G, Reum T, Ansorge M, Kusserow H, Winter C, Morgenstern R, Kupsch A: High-frequency stimulation of the subthalamic nucleus enhances striatal dopamine release and metabolism in rats. J Neurochem 2003;85:601-609.
47. Meissner W, Harnack D, Paul G, Reum T, Sohr R, Morgenstern R, Kupsch A: Deep brain stimulation of the subthalamic nucleus increases striatal dopamine metabolism and induces contralateral circling in freely moving 6-hydroxydopamine-lesioned rats. Neurosci Lett 2002;328:105-108.
48. Eidelberg D, Edwards C: Functional brain imaging of movement disorders. Neurol Res 2000;22:305-312.
49. Zhao YB, Sun BM, Li DY, Wang QS: Effects of bilateral subthalamic nucleus stimulation on resting-state cerebral glucose metabolism in advanced Parkinson's disease. Chin Med J (Engl) 2004;117:1304-1308.